J E Janik|D L Longo - JoVE Visualize

Showing results (81-90 of 406) with videos related to

Pageof 41

Sort By:

Cancer Research|October 15, 1987

Lymphokine-activated killer cells: culture conditions for the generation of maximal in vitro cytotoxicity in cells from normal donorsS K Beckner, A E Maluish, D L Longo

Immunologic Research|January 1, 1988

Influence of bone marrow-derived Ia-bearing cells on the selection of the T-cell repertoireL A Matis, S E Heckford, D L Longo

Journal of Virology|October 1, 1981

Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replicationR M Buller, J E Janik, E D Sebring, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996

Phase I study of subcutaneously administered interleukin-2 in combination with interferon alfa-2a in patients with advanced cancerB L Gause, M Sznol, W C Kopp, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1992

Donor-type activated natural killer cells promote marrow engraftment and B cell development during allogeneic bone marrow transplantationW J Murphy, M Bennett, V Kumar, et al.

Blood|August 1, 1992

MYC rearrangements in histologically progressed follicular lymphomasT Yano, E S Jaffe, D L Longo, et al.

Journal of Clinical Apheresis|January 1, 1983

Therapeutic cytapheresis in chronic lymphocytic leukemiaG E Marti, T Folks, D L Longo, et al.

Clinical Immunology (Orlando, Fla.)|December 22, 1999

Treatment with tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patientsJ E Janik, L L Miller, W C Kopp, et al.

Journal of the National Cancer Institute. Monographs|January 1, 1990

Treatment of Hodgkin's diseaseV T De Vita, S M Hubbard, D L Longo

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 1, 1993

Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiationK Hirose, D L Longo, J J Oppenheim, et al.

Pageof 41

Showing results (81-90 of 406) with videos related to

Sort By:

Pageof 41

Cancer Research|October 15, 1987

Lymphokine-activated killer cells: culture conditions for the generation of maximal in vitro cytotoxicity in cells from normal donorsS K Beckner, A E Maluish, D L Longo

Immunologic Research|January 1, 1988

Influence of bone marrow-derived Ia-bearing cells on the selection of the T-cell repertoireL A Matis, S E Heckford, D L Longo

Journal of Virology|October 1, 1981

Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replicationR M Buller, J E Janik, E D Sebring, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996

Phase I study of subcutaneously administered interleukin-2 in combination with interferon alfa-2a in patients with advanced cancerB L Gause, M Sznol, W C Kopp, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1992

Donor-type activated natural killer cells promote marrow engraftment and B cell development during allogeneic bone marrow transplantationW J Murphy, M Bennett, V Kumar, et al.

Blood|August 1, 1992

MYC rearrangements in histologically progressed follicular lymphomasT Yano, E S Jaffe, D L Longo, et al.

Journal of Clinical Apheresis|January 1, 1983

Therapeutic cytapheresis in chronic lymphocytic leukemiaG E Marti, T Folks, D L Longo, et al.

Clinical Immunology (Orlando, Fla.)|December 22, 1999

Treatment with tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patientsJ E Janik, L L Miller, W C Kopp, et al.

Journal of the National Cancer Institute. Monographs|January 1, 1990

Treatment of Hodgkin's diseaseV T De Vita, S M Hubbard, D L Longo

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 1, 1993

Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiationK Hirose, D L Longo, J J Oppenheim, et al.

Pageof 41